A simple solution for complex problems


Business Summary


StelaGenomics, launched in 2011, is a Delaware C Corporation headquartered in Santa Clara, California with operations in both United States and Mexico. The company owns the exclusive worldwide rights to the IP portfolio developed by Dr. Luis Herrera Estrella, a world leader and pioneer of plant transgenic technology which enables a more rational, eco‐friendly, control of weeds and use of fertilizers in modern high‐yield agriculture.


The platform technology developed has also important uses in other areas such as in microalgae cultures and selection markers. StelaGenomics in 2013  completed its first field tests for tobacco with favorable results, and has successfully transformed five major crops, owning a strong IP portfolio in main agriculture markets.





- Agro‐Biotech

- Ecofriendly Biotech/Genome Editing Crops/Biomaterials.

- Biomaterials production from microalgae.

- Phosphite based dual fertilizer/herbicide.

- Selection markers.




Become the world leader platform in environmentally friendly agriculture/bioproducts.



Dr. Luis Herrera Ph.D., MEX, Founder and Chairman of the Scientific Advisory Board. Founder and Director of LANGEBIO (National Laboratory of Genomics for Biodiversity), National Prize of Sciences and a world renowned pioneer and inventor in the field of transgenic plants. Member of the US Academy of Sciences and has received many international prizes and honors.

Paulo Arruda Ph.D., Brazil, Business & Scientific Advisor of the Board :  Founder and Director of the Center for Molecular Biology and Genetic Engineering at the University of Campinas, Co-founder of the Brazilian Genome Network and the sugarcane genome network of Brazilian laboratories. Co-founder and Scientific Director of Alellyx Applied Genomics, the first private Latin American plant biotechnology company focused on genomics acquired in 2008 by Monsanto in $290 million.

John Andrew Ryals, Ph.D., USA, Business & Scientific Advisor of the Board. President, Chief Executive Officer, Founder, Board Member, of Metabolon, Inc.,  Founder and CEO of Paradigm Genetics, Inc., Responsible for the initial business plan and obtaining all rounds of equity financing. Raised $105 million in investment capital and took the company public in two years. Initiated and negotiated over $200 million in external partnerships. Dr. Ryals has over 30 years’ experience in the Agro and Pharma biotechnology industries.

Damar Lopez , Ph.D., MEX, Director of Research StelaGenomics Mexico. She was IN 2012 selected as the Innovator of the Year “TR35 Mexico” by MIT’s Technology Review. She received the Weismann, National Science Academy of Mexico and Agrobio awards, and is co-author of several international patents and co-inventor of the PRS.

Gerardo V. Toledo, Ph.D., USA, Business & Scientific Advisor of the Board,  USA. 16 years working experience in the biotechnology industry in La Jolla, CA and Cambridge, MA developing high throughput strategies for microbial discovery with commercial outcomes. 2014 – 2017 Indigo Ag, Vice President Collaborations/Vice President Discovery, 2006 – 2014 Synthetic Genomics Inc. Senior Director, Microbial Discovery, NASA Bioteleportation.


StelaGenomics has develop an international network of partnerships for the various applications of our technology, this includes some of the most prestigious research centers, universities and businesses of the sector, among others are the following.